| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |